Table 2: Effectiveness of maintenance therapy using oral IV ganciclovir in delaying first progression of cytomegalovirus (CMV) retinitis

                                              Cooperative
                                              Study         Rachlis
                               Drew et al(8)  Group(10)     et al(23)

IV Oral IV Oral IV Oral
Mean time to first progression of CMV retinitis (days) 62 57 66 54 62 51
Patients with deterioration of visual acuity(%) 25 20 16 19 11 16
Note: The number of patients in the three studies were 121, 225 and 159; and their median CD4+ counts were 9.5 cells/mm3, 7 cells/mm3 and 10 cells/mm3, respectively.
Return to text